Theodore Daniel Zucconi - Net Worth and Insider Trading
Theodore Daniel Zucconi Net Worth
The estimated net worth of Theodore Daniel Zucconi is at least $3,195 dollars as of 2024-11-13. Theodore Daniel Zucconi is the Director of Galectin Therapeutics Inc and owns about 1,083 shares of Galectin Therapeutics Inc (GALT) stock worth over $3,195. Details can be seen in Theodore Daniel Zucconi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Theodore Daniel Zucconi has not made any transactions after 2018-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Theodore Daniel Zucconi
Theodore Daniel Zucconi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Theodore Daniel Zucconi owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Theodore Daniel Zucconi’s form 4 insider trades.
Insider Ownership Summary of Theodore Daniel Zucconi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GALT | Galectin Therapeutics Inc | 2018-04-16 | director |
Theodore Daniel Zucconi Latest Holdings Summary
Theodore Daniel Zucconi currently owns a total of 1 stock. Theodore Daniel Zucconi owns 1,083 shares of Galectin Therapeutics Inc (GALT) as of April 16, 2018, with a value of $3,195.
Latest Holdings of Theodore Daniel Zucconi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GALT | Galectin Therapeutics Inc | 2018-04-16 | 1,083 | 2.95 | 3,195 |
Holding Weightings of Theodore Daniel Zucconi
Theodore Daniel Zucconi Form 4 Trading Tracker
According to the SEC Form 4 filings, Theodore Daniel Zucconi has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the sale of 4,000 shares on April 16, 2018, which brought Theodore Daniel Zucconi around $14,320.
Insider Trading History of Theodore Daniel Zucconi
- 1
Theodore Daniel Zucconi Trading Performance
GuruFocus tracks the stock performance after each of Theodore Daniel Zucconi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Theodore Daniel Zucconi is -26.5%. GuruFocus also compares Theodore Daniel Zucconi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Theodore Daniel Zucconi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Theodore Daniel Zucconi's insider trading performs compared to the benchmark.
Performance of Theodore Daniel Zucconi
Theodore Daniel Zucconi Ownership Network
Ownership Network List of Theodore Daniel Zucconi
Ownership Network Relation of Theodore Daniel Zucconi
Theodore Daniel Zucconi Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Theodore Daniel Zucconi is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Theodore Daniel Zucconi made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 15,300 shares, with a net purchase of 15,300 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Theodore Daniel Zucconi Mailing Address
Above is the net worth, insider trading, and ownership report for Theodore Daniel Zucconi. You might contact Theodore Daniel Zucconi via mailing address: Pro-pharmaceuticals Inc, 7 Wells Avenue Suite 34, Newton Ma 02459.